Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Differences in the amount of fetal hemoglobin (HbF) that persists into adulthood affect the severity of sickle cell disease and the β-thalassemia syndromes. Genetic association studies have identified sequence variants in the gene BCL11A that influence HbF levels. Here, we examine BCL11A as a potential regulator of HbF expression. The high-HbF BCL11A genotype is associated with reduced BCL11A expression. Moreover, abundant expression of full-length forms of BCL11A is developmentally restricted to adult erythroid cells. Down-regulation of BCL11A expression in primary adult erythroid cells leads to robust HbF expression. Consistent with a direct role of BCL11A in globin gene regulation, we find that BCL11A occupies several discrete sites in the β-globin gene cluster. BCL11A emerges as a therapeutic target for reactivation of HbF in β-hemoglobin disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The retention of both HBG genes, each with slightly different promoter sequences, also contributes to nuanced regulatory control and may influence HbF levels in adults, a feature of clinical relevance in disorders like β-thalassemia and sickle cell disease [97].”
From Origin and Evolution of Genes in Eukaryotes: Mechanisms, Dynamics, and Functional Implications (2025) · cites this paper as [97]
In the citing paper
“Reducing bcl11a expression in transgenic sickle mice derepressed g-globin genes.17,18”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [17]
In the citing paper
“current treatments aim to induce the expression of non-mutated fetal hemoglobin (HbF), which is functional but transcriptionally repressed post-birth (Sankaran et al. 2008).”
From From serendipity to strategy: molecular glue degraders in cancer therapeutics (2025) · cites this paper as Sankaran et al. 2008
In the citing paper
“Further molecular studies revealed that BCL11A interacts with several erythroid regulators including GATA1, FOG1, and SOX6, and with the nucleosome remodeling and deacetylase complex (NuRD) (4, 6).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [4]
In the citing paper
“We identi fi ed numerous peptides of BCL11A and nearly all previously established interacting proteins, including FOG1, the entire NuRD complex, and the nuclear matrix protein MATRIN-3 (4).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [4]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Self-citationA Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma
Moffatt, M. F., Kabesch, M., Liang, L., Dixon, A. L., Strachan, D., Heath, S., Depner, M., von Berg, A., Bufe, A., Rietschel, E., et al. (2007) · Nature · doi:10.1038/nature06014 · Cited by 1,604
A HapMap harvest of insights into the genetics of common disease
Manolio, T. A., Brooks, L. D., & Collins, F. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34772 · Cited by 889
Tsai, S.-F., Martin, D. I. K., Zon, L. I., D'Andrea, A. D., Wong, G. G., & Orkin, S. H. (1989) · Nature · doi:10.1038/339446a0 · Cited by 885
Self-citationTsang, A. P., Visvader, J. E., Turner, C. A., Fujiwara, Y., Yu, C., Weiss, M. J., Crossley, M., & Orkin, S. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80318-9 · Cited by 712
Self-citationUda, M., Galanello, R., Sanna, S., Lettre, G., Sankaran, V. G., Chen, W., Usala, G., Busonero, F., Maschio, A., Albai, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711566105 · Cited by 672
Self-citationLettre, G., Sankaran, V. G., Bezerra, M. A. C., Araújo, A. S., Uda, M., Sanna, S., Cao, A., Schlessinger, D., Costa, F. F., Hirschhorn, J. N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804799105 · Cited by 561
Self-citationA QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., et al. (2007) · Nature Genetics · doi:10.1038/ng2108 · Cited by 529
Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes
Göring, H. H. H., Curran, J. E., Johnson, M. P., Dyer, T. D., Charlesworth, J., Cole, S. A., Jowett, J. B. M., Abraham, L. J., Rainwater, D. L., Comuzzie, A. G., et al. (2007) · Nature Genetics · doi:10.1038/ng2119 · Cited by 504
Cited by
Items 301–400 of 1,001
Teofili, L., Papacci, P., Pellegrino, C., Dani, C., Cresi, F., Remaschi, G., Ansaldi, G., Giannantonio, C., Campagnoli, M. F., Vania, B., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103426 · Cited by 41
MicroRNAs: Allies or Foes in erythropoiesis?
Byon, J. C. H., & Papayannopoulou, T. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22729 · Cited by 41
NRF2 mediates γ-globin gene regulation and fetal hemoglobin induction in human erythroid progenitors
Zhu, X., Li, Y., & Pace, B. S. (2017) · Haematologica · doi:10.3324/haematol.2016.160788 · Cited by 41
Mutations in cis that affect mRNA synthesis, processing and translation
Roos, D., & de Boer, M. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166166 · Cited by 41
Current advances of CRISPR-Cas technology in cell therapy
Qiu, H.-Y., Ji, R.-J., & Zhang, Y. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100067 · Cited by 41
Genetic architecture of hemoglobin F control
Menzel, S., & Thein, S. L. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328329d07a · Cited by 37
Modifier genes in Mendelian disorders: the example of hemoglobin disorders
Sankaran, V. G., Lettre, G., Orkin, S. H., & Hirschhorn, J. N. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05821.x · Cited by 40
Self-citationTargeted Fetal Hemoglobin Induction for Treatment of Beta Hemoglobinopathies
Perrine, S. P., Pace, B. S., & Faller, D. V. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.11.009 · Cited by 40
Pereira, C., Relvas, L., Bento, C., Abade, A., Ribeiro, L., & Manco, L. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.02.001 · Cited by 40
van Besien, K., Liu, H., Jain, N., Stock, W., & Artz, A. S. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.11.001 · Cited by 40
Disruption of the Hbs1l-Myb Locus Causes Hereditary Persistence of Fetal Hemoglobin in a Mouse Model
Suzuki, M., Yamazaki, H., Mukai, H. Y., Motohashi, H., Shi, L., Tanabe, O., Engel, J. D., & Yamamoto, M. P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01617-12 · Cited by 40
Urbinati, F., Hargrove, P. W., Geiger, S., Romero, Z. G., Wherley, J., Kaufman, M. L., Hollis, R. P., Chambers, C. B., Persons, D. A., Kohn, D. B., et al. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.01.009 · Cited by 40
Genetic therapies for sickle cell disease
Esrick, E. B., & Bauer, D. E. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.04.014 · Cited by 41
Zhou, T., Zhu, X., Ye, Z., Wang, Y., Yao, C., Xu, N., Zhou, M., Ma, J., Qin, Y., Shen, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29514-y · Cited by 40
Milton, J. N., Gordeuk, V. R., Taylor, J. G., Gladwin, M. T., Steinberg, M. H., & Sebastiani, P. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000387 · Cited by 40
Bernaudin, F., Arnaud, C., Kamdem, A., Hau, I., Lelong, F., Epaud, R., Pondarré, C., & Pissard, S. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017014555 · Cited by 40
King, A. J., & Higgs, D. R. (2018) · Hematology · doi:10.1182/asheducation-2018.1.353 · Cited by 40
Current and Future Therapeutics for Treating Patients with Sickle Cell Disease
Barak, M., Hu, C., Matthews, A. K., & Fortenberry, Y. M. (2024) · Cells · doi:10.3390/cells13100848 · Cited by 39
CRISPR-based therapeutic genome editing for inherited blood disorders
Levesque, S., & Bauer, D. E. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01236-y · Cited by 39
Molecular Medicine: Found in Translation
Orkin, S. H. (2021) · Med · doi:10.1016/j.medj.2020.12.011 · Cited by 39
Self-citationGenome-wide association studies of hematologic phenotypes: a window into human hematopoiesis
Sankaran, V. G., & Orkin, S. H. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.02.006 · Cited by 33
Self-citationBlood group phenotypes resulting from mutations in erythroid transcription factors
Singleton, B. K., Frayne, J., & Anstee, D. J. (2012) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328358f92e · Cited by 39
Moleirinho, A., Seixas, S., Lopes, A. M., Bento, C., Prata, M. J., & Amorim, A. (2013) · Genome Biology and Evolution · doi:10.1093/gbe/evt029 · Cited by 39
Induction of Fetal HemoglobinIn VivoMediated by a Syntheticγ-Globin Zinc Finger Activator
Costa, F. C., Fedosyuk, H., Neades, R. Y., Rios, J. B. D. L., Barbas, C. F., & Peterson, K. R. (2012) · Anemia · doi:10.1155/2012/507894 · Cited by 39
14q32 and let-7 microRNAs regulate transcriptional networks in fetal and adult human erythroblasts
Lessard, S., Beaudoin, M., Orkin, S. H., Bauer, D. E., & Lettre, G. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy051 · Cited by 38
Self-citationGudmundsdottir, B., Gudmundsson, K. O., Klarmann, K. D., Singh, S. K., Sun, L., Singh, S., Du, Y., Coppola, V., Stockwin, L. H., Nguyen, N., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.043 · Cited by 38
Netsrithong, R., Suwanpitak, S., Boonkaew, B., Trakarnsanga, K., Chang, L., Tipgomut, C., Vatanashevanopakorn, C., Pattanapanyasat, K., & Wattanapanitch, M. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01997-w · Cited by 39
Choi, S. R., Hwang, C. Y., Lee, J., & Cho, K. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0621 · Cited by 38
CRISPR/Cas-based gene editing in therapeutic strategies for beta-thalassemia
Zeng, S., Lei, S.-Y., Qu, C., Wang, Y., Teng, S., & Huang, P. C. (2023) · Human Genetics · doi:10.1007/s00439-023-02610-9 · Cited by 38
Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
Zakaria, N. A., Islam, M. A., Abdullah, W. Z., Bahar, R., Yusoff, A. A. M., Wahab, R. A., Shamsuddin, S., & Johan, M. F. (2021) · Biomolecules · doi:10.3390/biom11050755 · Cited by 37
BCL11A promotes myeloid leukemogenesis by repressing PU.1 target genes
Sunami, Y., Yokoyama, T., Yoshino, S., Takahara, T., Yamazaki, Y., Harada, H., & Nakamura, T. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004558 · Cited by 37
Ferraresi, M., Panzieri, D. L., Leoni, S., Cappellini, M. D., Kattamis, A., & Motta, I. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-04900-w · Cited by 38
Pathophysiology and recent therapeutic insights of sickle cell disease
Shah, F., & Dwivedi, M. (2020) · Annals of Hematology · doi:10.1007/s00277-020-03977-9 · Cited by 36
Casanova, J. (2025) · Journal of Human Immunity · doi:10.70962/jhi.20250001 · Cited by 36
A unified model of human hemoglobin switching through single-cell genome editing
Shen, Y., Verboon, J. M., Zhang, Y., Liu, N., Kim, Y. J., Marglous, S., Nandakumar, S. K., Voit, R. A., Fiorini, C., Ejaz, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25298-9 · Cited by 36
Self-citationBrain malformations in a patient with deletion 2p16.1: A refinement of the phenotype to BCL11A
Balci, T. B., Sawyer, S. L., Dávila, J., Humphreys, P., & Dyment, D. A. (2015) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2015.04.006 · Cited by 36
Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia
Bao, X., Zhang, X., Wang, L., Wang, Z., Huang, J., Zhang, Q., Ye, Y., Liu, Y., Chen, D., Zuo, Y., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.03.005 · Cited by 35
Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy
Rosanwo, T. O., & Bauer, D. E. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.10.002 · Cited by 35
Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials
Segura, E., Ayoub, P. G., Hart, K. L., & Kohn, D. B. (2023) · Viruses · doi:10.3390/v15030713 · Cited by 35
Kumkhaek, C., Aerbajinai, W., Liu, W., Zhu, J., Uchida, N., Kurlander, R. J., Hsieh, M. M., Tisdale, J. F., & Rodgers, G. P. (2013) · Blood · doi:10.1182/blood-2011-10-385252 · Cited by 35
Original Research: Stable expression of miR-34a mediates fetal hemoglobin induction in K562 cells
Ward, C. M., Li, Y., & Pace, B. S. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216636725 · Cited by 35
Pellegrino, C., Stone, E. F., Valentini, C. G., & Teofili, L. (2024) · Cells · doi:10.3390/cells13221843 · Cited by 34
Recent challenges and advances in genetically-engineered cell therapy
Yong, S., Chung, J. Y., Song, Y., & Kim, Y. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0381-1 · Cited by 34
The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells
Lan, X., Khandros, E., Huang, P., Peslak, S. A., Bhardwaj, S. K., Grevet, J. D., Abdulmalik, O. Y., Wang, H., Keller, C. A., Giardine, B. M., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019032318 · Cited by 34
Wang, F., Ling, L., & Yu, D. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.02.011 · Cited by 34
Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies
Paschoudi, K., Yannaki, E., & Psatha, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119527 · Cited by 34
Transcription factor networks disproportionately enrich for heritability of blood cell phenotypes
Martin-Rufino, J. D., Caulier, A., Lee, S., Castano, N., King, E., Joubran, S. R., Jones, M. K., Goldman, S. R., Arora, U. P., Wahlster, L., et al. (2025) · Science · doi:10.1126/science.ads7951 · Cited by 33
Self-citationAltrock, P. M., Brendel, C., Renella, R., Orkin, S. H., Williams, D. A., & Michor, F. (2016) · American Journal of Hematology · doi:10.1002/ajh.24449 · Cited by 30
Self-citationPakdee, N., Yamsri, S., Fucharoen, G., Sanchaisuriya, K., Pissard, S., & Fucharoen, S. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.02.005 · Cited by 33
Liu, L., Pertsemlidis, A., Ding, L.-H., Story, M. D., Steinberg, M. H., Sebastiani, P., Hoppe, C. C., Ballas, S. K., & Pace, B. S. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216642047 · Cited by 33
Zhou, L., Wu, J., Wang, W., Yu, W., Zhao, G., Zhang, P., Xiong, J., Li, M., Xue, Z., Wang, X., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.355271 · Cited by 33
Guo, X., Plank-Bazinet, J. L., Krivega, I. V., Dale, R., & Dean, A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa736 · Cited by 32
The secreted lymphangiogenic factor CCBE1 is essential for fetal liver erythropoiesis
Zou, Z., Enis, D. R., Bui, H., Khandros, E., Kumar, V., Jakus, Z., Thom, C. S., Yang, Y., Dhillon, V., Chen, M., et al. (2013) · Blood · doi:10.1182/blood-2012-10-462689 · Cited by 32
Studying the altered timing of physiological events during development: It's about time…or is it?
Spicer, J. I., Rundle, S. D., & Tills, O. (2011) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2011.06.005 · Cited by 32
Genomic approaches to identifying targets for treating β hemoglobinopathies
Ngo, D., & Steinberg, M. H. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0120-2 · Cited by 32
Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond?
Banan, M. (2013) · Annals of Hematology · doi:10.1007/s00277-012-1671-3 · Cited by 32
Targeting sickle cell disease root-cause pathophysiology with small molecules
Saunthararajah, Y. (2019) · Haematologica · doi:10.3324/haematol.2018.207530 · Cited by 32
Ball, J., Bradley, A., Le, A., Tisdale, J. F., & Uchida, N. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.016 · Cited by 31
The genetics of hemoglobin A2 regulation in sickle cell anemia
Griffin, P. J., Sebastiani, P., Edward, H. L., Baldwin, C. T., Gladwin, M. T., Gordeuk, V. R., Chui, D. H. K., & Steinberg, M. H. (2014) · American Journal of Hematology · doi:10.1002/ajh.23811 · Cited by 31
Genetic modifiers of severity in sickle cell disease
Chang, A. K., Summarell, C. C. G., Birdie, P. T., & Sheehan, V. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189004 · Cited by 31
Gene Therapy for Beta-Hemoglobinopathies: Milestones, New Therapies and Challenges
Ghiaccio, V., Chappell, M., Rivella, S., & Breda, L. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00383-4 · Cited by 31
Chambers, C. B., Gross, J., Pratt, K. L., Guo, X., Byrnes, C., Lee, Y. T., Lavelle, D., Dean, A., Miller, J. L., & Wilber, A. C. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.01.011 · Cited by 32
Augmenting and directing long-range CRISPR-mediated activation in human cells
Tak, Y. E., Horng, J. E., Perry, N. T., Schultz, H. T., Iyer, S., Yao, Q., Zou, L. S., Aryee, M. J., Pinello, L., & Joung, J. K. (2021) · Nature Methods · doi:10.1038/s41592-021-01224-1 · Cited by 31
Beta‐thalassemia and the advent of new interventions beyond transfusion and iron chelation
Chauhan, W., Shoaib, S., Fatma, R., Zaka‐ur‐Rab, Z., & Afzal, M. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15343 · Cited by 32
Li, S., Teegarden, A., Bauer, E. M., Choi, J., Messaddeq, N., Hendrix, D. A., Ganguli-Indra, G., Leid, M., & Indra, A. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-13347-7 · Cited by 27
Embryonic and fetal human hemoglobins: structures, oxygen binding, and physiological roles
Manning, J. M., Manning, L. R., Dumoulin, A., Padovan, J. C., & Chait, B. (2020) · Subcellular Biochemistry · doi:10.1007/978-3-030-41769-7_11 · Cited by 30
Costa, F. C., Fedosyuk, H., Chazelle, A. M., Neades, R. Y., & Peterson, K. R. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003155 · Cited by 30
Generation of Red Blood Cells from Human Pluripotent Stem Cells—An Update
Lee, S., Jung, C., Oh, J. E., Kim, S., Lee, S., Lee, J. Y., & Yoon, Y. (2023) · Cells · doi:10.3390/cells12111554 · Cited by 31
Genomics of drug target prioritization for complex diseases
Chen, R. K., Duffy, Á., & Do, R. (2025) · Nature Reviews Genetics · doi:10.1038/s41576-025-00904-4 · Cited by 30
Cellular Basis of Embryonic Hematopoiesis and Its Implications in Prenatal Erythropoiesis
Yamane, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249346 · Cited by 30
Liu, B., Brendel, C., Vinjamur, D. S., Zhou, Y., Harris, C. E., McGuinness, M. K., Manis, J. P., Bauer, D. E., Xu, H., & Williams, D. A. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.05.002 · Cited by 30
Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option
Starlard‐Davenport, A., Gu, Q., & Pace, B. S. (2022) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-022-00589-z · Cited by 31
Evolution of nanobodies specific for BCL11A
Yin, M., Izadi, M., Tenglin, K., Viennet, T., Zhai, L., Zheng, G., Arthanari, H., Dassama, L. M. K., & Orkin, S. H. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2218959120 · Cited by 30
Self-citationFetal Hemoglobin Regulation in Beta-Thalassemia
Lu, H. Y., Orkin, S. H., & Sankaran, V. G. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.12.002 · Cited by 30
Self-citationFanis, P., Kousiappa, I., Phylactides, M., & Kleanthous, M. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-108 · Cited by 30
Diagnosis and prevention of thalassemia
Ip, H., & So, C. C. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.847236 · Cited by 30
Alternative options for DNA-based experimental therapy of β-thalassemia
Gambari, R. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.665047 · Cited by 30
Piragyte, I., Clapes, T., Polyzou, A., Geltink, R. I. K., Lefkopoulos, S., Yin, N., Cauchy, P., Curtis, J. D., Klaeylé, L., Langa, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05311-4 · Cited by 30
Downregulation of BCL11A by siRNA induces apoptosis in B lymphoma cell lines
Gao, Y., Wu, H., He, D., Hu, X., & Li, Y. (2012) · Biomedical Reports · doi:10.3892/br.2012.9 · Cited by 30
Correction of Beta-Thalassemia IVS-II-654 Mutation in a Mouse Model Using Prime Editing
Zhang, H., Sun, R., Fei, J., Chen, H., & Lu, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115948 · Cited by 30
Recent advancements in gene therapy for sickle cell disease and β-thalassemia
Li, L., & Mandal, P. K. (2024) · Frontiers in Hematology · doi:10.3389/frhem.2024.1468952 · Cited by 29
Erythropoiesis: insights from a genomic perspective
Ji, H. Y. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01311-1 · Cited by 30
Fromm, G. J., & Bulger, M. (2009) · Biochemistry and Cell Biology · doi:10.1139/o09-048 · Cited by 29
Fontana, L., Alahouzou, Z., Miccio, A., & Antoniou, P. (2023) · Genes · doi:10.3390/genes14030577 · Cited by 29
Histone Deacetylase 9 Activates γ-Globin Gene Expression in Primary Erythroid Cells
Muralidhar, S. A., Ramakrishnan, V., Kalra, I. S., Li, W., & Pace, B. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.115725 · Cited by 29
Chin, J., Singh, M., Banzon, V., Vaitkus, K., Ibañez, V., Kouznetsova, T., Mahmud, N., DeSimone, J., & Lavelle, D. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.06.007 · Cited by 29
Ali, G., Tariq, M. A., Shahid, K., Ahmad, F. J., & Akram, J. (2020) · Gene Therapy · doi:10.1038/s41434-020-0153-9 · Cited by 29
Future alternative therapies for β-thalassemia
Rivella, S., & Rachmilewitz, E. A. (2009) · Expert Review of Hematology · doi:10.1586/ehm.09.56 · Cited by 29
Abnormal regulation of microRNAs and related genes in pediatric β‐thalassemia
Wang, H., Chen, M., Xu, S., Pan, Y., Zhang, Y., Huang, H., & Xu, L. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23945 · Cited by 28
DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression
Price, J. D., Lindtner, S., Ypsilanti, A. R., Binyameen, F., Johnson, J. R., Newton, B. W., Krogan, N. J., & Rubenstein, J. L. R. (2022) · Development · doi:10.1242/dev.199508 · Cited by 28
Haemoglobin and the Inherited Disorders of Globin Synthesis
Thein, S. L., & Rees, D. C. (2015) · Wiley eBooks · doi:10.1002/9781118853771.ch6 · Cited by 28
Ochi, K., Takayama, N., Hirose, S.-I., Nakahata, T., Nakauchi, H., & Eto, K. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0216 · Cited by 28
PGC-1 Coactivator Activity Is Required for Murine Erythropoiesis
Cui, S., Tanabe, O., Lim, K.-C., Xu, H. E., Zhou, X. E., Lin, J. D., Shi, L., Schmidt, L. A., Campbell, A., Shimizu, R., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00247-14 · Cited by 28
Chan, C. M., Fulton, J., Montiel‐Duarte, C., Collins, H. M., Bharti, N., Wadelin, F. R., Moran, P. M., Mongan, N. P., & Heery, D. M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt761 · Cited by 28
Hosey, A. M., Chaturvedi, C.-P., & Brand, M. (2010) · Epigenetics · doi:10.4161/epi.5.4.11522 · Cited by 28
Expression of fetal hemoglobin in adult humans exposed to high altitude hypoxia
Risso, A., Fabbro, D., Damante, G., & Antonutto, G. (2012) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2011.12.004 · Cited by 28
Gallienne, A. E., Dreau, H. M.-P., McCarthy, J., Timbs, A., Hampson, J. M., Schuh, A., Old, J., & Henderson, S. J. (2009) · Hemoglobin · doi:10.3109/03630260903344564 · Cited by 28
The mouse alpha-globin cluster: a paradigm for studying genome regulation and organization
Oudelaar, A. M., Beagrie, R. A., Kassouf, M. T., & Higgs, D. R. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.10.003 · Cited by 27
Investigational drugs in phase I and phase II clinical trials for thalassemia
Motta, I., Scaramellini, N., & Cappellini, M. D. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1335709 · Cited by 27
Barbarani, G., Fugazza, C., Strouboulis, J., & Ronchi, A. E. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00091 · Cited by 27
Metadata
- Authors
- Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H.
- Affiliations
- Broad Institute (US)
- Division of Hematology/Oncology, Children's Hospital Boston, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA.
- Corresponding author
- Orkin, Stuart H.
- ORCID
- Venue
- Science
- Published
- 2008-12-19
- Volume
- 322
- Issue
- 5909
- Pages
- 1839-1842
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1968165696
- Semantic Scholar
- a52e99500fd26811a2ae248d6dce95e3152b5bb7
- Cited by
- 919
- References
- 27
- Citations by year
- 2026: 59 · 2025: 46 · 2024: 55 · 2023: 52 · 2022: 47 · 2021: 73 · 2020: 70 · 2019: 31 · 2018: 50 · 2017: 59 · 2016: 63 · 2015: 46 · 2014: 45 · 2013: 53 · 2012: 49
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (HL32262-26, P01HL032262, R01HL032259, HL32259-27)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- fetal hemoglobin, BCL11A, globin gene regulation, beta-globin gene cluster, sickle cell disease, beta-thalassemia, erythroid cells, therapeutic target
- MeSH terms
- Animals, Carrier Proteins, Cells, Cultured, Erythroblasts, Erythropoiesis, Fetal Hemoglobin, Gene Expression Regulation, Multigene Family, Hemoglobinopathies, Histone Deacetylases, Humans, Nuclear Proteins, Repressor Proteins, Transcription Factors, Transcription, Genetic, Down-Regulation, Erythroid Precursor Cells, K562 Cells, Protein Isoforms, Polymorphism, Single Nucleotide, RNA Interference, Erythroid Cells, Cell Line, Tumor, GATA1 Transcription Factor, Mice, beta-Globins, gamma-Globins, Mi-2 Nucleosome Remodeling and Deacetylase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.